000			01539nam a2200277Ia 4500
003			MX-MdCICY
005			20250625153921.0
040			_cCICY
090			_aB-13381
245	1	0	_aComparison of alamar blue and MTT assays for high through-put screening
490	0		_vToxicology in Vitro, 18(5), p.703-710, 2004
520	3		_aThe performance of alamar blue and 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT)cell viability assays in a high through-put format were compared. A total of 117 drugs chosen for their wide range of therapeutic areas were screened at 10 lM using both assays in human hepatoma cell line HepG2. Except for terfenadine and astemizole, which performed consistently in both assays, the alamar blue assay was slightly more sensitive than the MTT assay for most compounds. The MTT assay was less sensitive detecting an effect for daunorubicin and trifluoperazine. Seven drugs, astemizole, daunorubicin, ellipticine, fluphenazine, terfenadine, thioridazine and trifluoperazine, had percent viability results of 55
650	1	4	_aHEPG2
650	1	4	_aALAMAR BLUE
650	1	4	_aMTT
650	1	4	_aASSAY
650	1	4	_aHTS
700	1	2	_aHamid, R.
700	1	2	_aRotshteyn, Y.
700	1	2	_aRabadi, L.
700	1	2	_aParikh, R.
700	1	2	_aBullock, P.
856	4	0	_uhttps://drive.google.com/file/d/1TWxP4sWvBek167qpxJ2Wwg7WFbEhZHMj/view?usp=drivesdk _zPara ver el documento ingresa a Google con tu cuenta: @cicy.edu.mx
942			_2Loc _cREF1
008			250602s9999 xx |||||s2 |||| ||und|d
999			_c47581 _d47581